Fabbio Patrick 4
4 · Protara Therapeutics, Inc. · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
Protara (TARA) CFO Fabbio Patrick Withholds 3,261 Shares for Taxes
What Happened
Fabbio Patrick, Chief Financial Officer of Protara Therapeutics (TARA), had 3,261 shares disposed on January 26, 2026 as a tax-withholding payment tied to the vesting of restricted stock units. The shares were valued at $6.67 each for a total of approximately $21,751. This was a withholding transaction to satisfy income tax obligations rather than an open-market sale or a new purchase.
Key Details
- Transaction date and price: 2026-01-26, 3,261 shares at $6.67 each (total ≈ $21,751).
- Transaction type/code: F — shares withheld to pay tax liability on RSU vesting.
- Footnote: The shares were withheld to satisfy taxes on an RSU award granted to Patrick on January 24, 2025 (footnote F1).
- Shares owned after transaction: Not specified in the Form 4 filing.
- Filing: Reported on 2026-01-27 (appears timely).
Context
This was a routine tax-withholding disposition stemming from RSU vesting (a form of compensation). Such withholdings are standard and do not necessarily indicate the insider's view of the company’s prospects; they simply satisfy tax obligations rather than represent a deliberate investment decision.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-01-26$6.67/sh−3,261$21,751→ 64,115 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.